SCHEMBL15097694

SCHEMBL15097694

Ic1ccc(-c2ccccc2)nc1

nearest known ligand 0.52

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ LDHA P00338 1/20 0.52
▸ CYP11B1 P15538 9/20 0.46
▸ CYP11B2 P19099 9/20 0.46
▸ HPGDS O60760 1/20 0.46
▸ MIF P14174 1/20 0.45
▸ BAZ2B Q9UIF8 1/20 0.44
▸ MEN1 O00255 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4390590 0.80 CCR1 (0.46) RAB9A
SCHEMBL20862075 0.78 NPC1 (0.53) CYP11B1CYP11B2MEN1RAB9AKMT2A
SCHEMBL15907498 0.78 NPC1 (0.49) MEN1RAB9AKMT2A
SCHEMBL23504950 0.78 CYP11B1 (0.43) CYP11B1CYP11B2MEN1RAB9AKMT2A
SCHEMBL20098748 0.78 KDM1A (0.49) MEN1RAB9AKMT2ACYP3A4
SCHEMBL23632228 0.78 KDM1A (0.49) MEN1RAB9AKMT2A
SCHEMBL19992669 0.78 KDM1A (0.49) MEN1RAB9AKMT2A
SCHEMBL12973036 0.78 HPGDS (0.60) LDHACYP11B1CYP11B2HPGDSBAZ2B
SCHEMBL17860701 0.77 KDM1A (0.54) —
SCHEMBL6863681 0.77 HPGDS (0.56) CYP11B1HPGDSMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3858945-B1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORP (US) 2023-11-29 — — EP disclosed
US-20230287011-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-09-14 — — US disclosed
EP-3858945-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES Universal Display Corporation (US) 2021-08-04 — — EP disclosed
WO-2021135182-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS 陕西莱特光电材料股份有限公司 2021-07-08 — — WO disclosed
WO-2021049843-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2021-03-18 — — WO disclosed
EP-3502106-B1 TRIAZINE COMPOUNDS SUBSTITUTED WITH BULKY GROUPS NOVALED GMBH (DE) 2020-09-02 — — EP disclosed
EP-2736338-B1 FUSED TRICYCLIC COMPOUNDS AS mTOR INHIBITORS MERCK SHARP & DOHME (US) 2019-01-23 — — EP disclosed
EP-2612669-A2 USE OF THE FETAL REPROGRAMMING OF A PPAR AGONIST SNU R & DB Foundation (KR) 2013-07-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287011-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OXGR1, OCIAD1 LDHA 273/4885CYP11B1 2865/4885CYP11B2 2373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback